ATLANTA - Eric Donys Simeu, a/k/a Martell Collins, a citizen of Cameroon, has been arraigned on federal charges of conspiracy, wire fraud, computer fraud and access device fraud. Simeu was indicted by a federal grand jury in Atlanta on September 23, 2014.

“Cybercrime is borderless, but increasingly, so too are our law enforcement capabilities,” said U.S. Attorney John Horn. “With the cooperation of France and our international law enforcement partners, we were able to bring to justice a wanted fugitive who was allegedly committing cyber fraud that affected U.S. companies from the streets of West Africa.”

“Those who target US companies and citizens through cyber attacks and spear phishing emails can no longer be confident they will remain anonymous and be protected by geographic boundaries. The arrest and extradition of Eric Simeu is the result of a multi-national effort led by the FBI, which demonstrates the benefits of global cooperation among international law enforcement and the private sector. This arrest and extradition serves a strong deterrent to those targeting the computer networks of US companies and US citizens. It should also serve as a reminder to the public to be vigilant and aware they are frequently targeted through fraudulent emails seeking to steal their personal information,” said J. Britt Johnson, Special Agent in Charge, FBI Atlanta Field Office.

According to U.S. Attorney Horn, the charges, and other information presented in court: Eric Simeu is allegedly responsible for a series of “phishing campaigns” which targeted customers of Global Distribution System (“GDS”) companies from approximately July 2011 to September 2014.

A “phishing campaign” is the act of sending targeted emails to individuals for the purpose of acquiring usernames and passwords. The emails masquerade as an official communication from a legitimate company to gain the trust of the recipient and deceive them into providing protected information. GDS companies provide travel booking services to travel agencies and travel-related websites. Airline tickets that are issued from sources other than air carriers themselves are generally processed through a GDS company. Customers of GDS companies, such as representatives from a travel agency or travel-related website, are issued unique login credentials that are utilized to authenticate their identity and facilitate the issuance of airline tickets on GDS servers.

In this instance, Simeu’s alleged phishing campaigns targeted customers of two GDS Companies – one with its principal U.S. operations in Atlanta, Georgia, and another headquartered in Southlake, Texas. Simeu allegedly caused phishing emails to be delivered to customers of these GDS companies for the purpose of obtaining and stealing their unique log-in credentials. Simeu and others allegedly used the stolen log-in credentials to access the servers of the two GDS companies and cause the issuance of fraudulent airline tickets. Simeu and others then allegedly sold these airline tickets to customers, mostly in West Africa, for fractions of the actual cost, or used them for personal travel. The value of the fraudulently issued airline tickets exceeded $2 million.

On September 3, 2014, Simeu was arrested by French law enforcement pursuant to a federal criminal complaint issued out of the Northern District of Georgia. At the time of his arrest, Simeu was traveling from Casablanca, Morocco, to Paris, France, on an alleged fraudulently issued airline ticket in the name of his alias, Martell Collins, utilizing a fraudulent United Kingdom passport under the same name.

Eric Donys Simeu, a/k/a Martell Collins, 32, a citizen of Cameroon, was arraigned before United States Magistrate Judge Russell G. Vineyard. A federal grand jury in the Northern District of Georgia returned an indictment against Simeu on September 23, 2014. Simeu has been in French custody since his arrest in September 2014, pending completion of extradition proceedings.

Members of the public are reminded that the indictment only contains charges. The defendant is presumed innocent of the charges and it will be the government’s burden to prove the defendant’s guilt beyond a reasonable doubt at trial.

This case is being investigated by the Federal Bureau of Investigation and State Department Diplomatic Security Service.

Assistant United States Attorney Steven D Grimberg and Trial Attorney Peter Roman with the U.S. Department of Justice Computer Crime and Intellectual Property Section are prosecuting the case. The Justice Department’s Office of International Affairs also provided valuable assistance.

miércoles, 18 de mayo de 2016

Redwood Shores, Calif.—May
12, 2016

As more pharmaceutical companies outsource their clinical trials to contract research organizations (CROs), CROs are challenged to complete the clinical research in a more efficient and timely manner. Oracle Health Sciences today announced that Simbec-Orion Group Limited, a full service, international, boutique CRO, has adopted Oracle’s suite of eClinical cloud solutions to simplify the management of its customer’s clinical studies.

Oracle’s life sciences-specific solutions, combined with its broader product and service offering, are used by thousands of pharma, biopharma, and academic research centers worldwide to redesign clinical R&D processes, advance drug therapies, and optimize care delivery to improve the health, well-being, and lives of people globally.

“We reviewed a wide range of providers to ensure, that as a world-class CRO, we were working with the best–in-class systems”, said Ronald Openshaw, CEO, Simbec-Orion. “We chose to partner with Oracle, the market leader in eClinical solutions, as we wanted to rely upon an excellent, secure, robust, and state-of-the-art service that will meet current and foreseeable, future, market needs. We believe the scalability will drive efficiency in our work practices as we grow, especially in the light of increasingly complex clinical trials.”

“Oracle shares Simbec-Orion’s commitment to helping pharma and biotechnology companies deliver high-quality therapies to the patients we serve,” said Steve Rosenberg, senior vice president and general manager, Oracle Health Sciences. “ We look forward to working with Simbec-Orion as it further expands and enhances its clinical development services powered by our innovative technology.”

In 2014 through the merger of the two independent CROs, Simbec Research and Orion Clinical, Simbec-Orion Group was created as an international boutique CRO. Simbec-Orion Group now offers a full spectrum of drug development services from first-in-human Phase I clinical studies, through to pivotal Phase III studies and Phase IV post marketing studies. Starting in January 2016, unless the client expresses different requirements, new studies across the Simbec-Orion Group will use Oracle’s eClinical suite.

Healthcare organizations are under increasing pressure from regulatory agencies, consumers, employers, and governing boards to drive cost efficiency while maintaining quality patient care. Today’s healthcare systems are slow and expensive to maintain, especially when integrating a merged or acquired company. By standardizing on Oracle Modern Best Practice for Healthcare using embedded analytics, contextual social collaboration, and mobile technologies, healthcare organizations can achieve economies of scale faster to lower costs and access the innovative technologies to stay ahead of industry changes.

“Presbyterian Medical Services was looking for a complete cloud ERP solution that would help us drive efficiencies while maintaining quality patient care in a diverse, complex industry," said Chad Morris, senior ERP systems analyst, Presbyterian Medical Services. "In just 14 weeks, we were able to go live on Oracle ERP Cloud implementing a wide range of efficiencies with our 90+ locations across New Mexico. We are now in the process of going live on Oracle HCM Cloud."

Built on a secure and scalable architecture, Oracle ERP Cloud provides customers with flexible alternatives via full or modular adoption, seamless integration across clouds, on-premise and third party applications, standardized best practices and rapid implementation templates, as well as extensive support for global companies in a wide variety of industries, including healthcare. Oracle ERP Cloud delivers complete ERP capabilities across financials, procurement, and project portfolio management, as well as Enterprise Performance Management (EPM), Governance Risk and Compliance (GRC) and Supply Chain Management (SCM). The portfolio includes deep global and industry-specific capabilities and is fully integrated with Oracle Human Capital Management (HCM) and Customer Relationship Management (CRM) solutions.

Contact Info

About Oracle

Oracle offers a
comprehensive and fully integrated stack of cloud applications and platform
services. For more information about Oracle (NYSE:ORCL), visit www.oracle.com.

Trademarks

Oracle and Java are
registered trademarks of Oracle and/or its affiliates. Other names may be
trademarks of their respective owners.

Safe Harbor

The following is intended
to outline our general product direction. It is intended for information
purposes only, and may not be incorporated into any contract. It is not a
commitment to deliver any material, code, or functionality, and should not be
relied upon in making purchasing decisions. The development, release, and
timing of any features or functionality described for Oracle's products
remains at the sole discretion of Oracle Corporation.